Published in:
13-11-2023 | Care | Pancreatic Tumors
Association of Inpatient Palliative Care Consultation with Clinical and Financial Outcomes for Pancreatic Cancer
Authors:
Shineui Kim, BA, Nikhil Chervu, MS, MD, Alykhan Premji, MD, Saad Mallick, MD, Arjun Verma, BS, Konmal Ali, Peyman Benharash, MD, Timothy Donahue, MD
Published in:
Annals of Surgical Oncology
|
Issue 2/2024
Login to get access
Abstract
Background
Palliative care consultation (PCC) has been shown to improve quality of life and reduce costs for various chronic life-threatening diseases. Despite PCC incorporation into modern pancreatic cancer care guidelines, limited data regarding its specific utilization and impact on resource use is available.
Methods
The 2016–2020 Nationwide Readmissions Database was used to identify all adult hospitalizations entailing pancreatic cancer. Only patients with at least one readmission within 90 days were included to account for uncaptured out-of-hospital mortality. Multivariable regression models were used to ascertain the relationship between inpatient PCC during initial hospitalization and index as well as cumulative costs, overall length of stay (LOS), readmission rate, and number of repeat hospitalizations.
Results
Of an estimated 175,805 patients with pancreatic cancer, 11.1% had inpatient PCC during the index admission. PCC utilization significantly increased from 10.5% in 2016 to 11.6% in 2020 (nptrend < 0.001). After adjustment, PCC was associated with reduced index hospitalization costs [β: − $1100; 95% confidence interval (CI) − 1500, − 800; P < 0.001] and cumulative 90-day costs (β: − $11,700; 95% CI − 12,700, − 10,000; P < 0.001). PCC was associated with longer index LOS (β: + 1.12 days, 95% CI 0.92–1.31, P < 0.001) but significantly reduced cumulative LOS (β: − 3.16 days; 95% CI − 3.67, − 2.65; P < 0.001). Finally, PCC was linked with decreased odds of 30-day nonelective readmission (AOR: 0.48, 95% CI 0.45–0.50, P < 0.001).
Discussion
PCC was associated with decreased costs, readmission rates, and number of hospitalizations among patients with pancreatic cancer. Directed strategies to increase utilization and reduce barriers to consultation should be implemented to encourage practitioners to maximize inpatient PCC referral rates.